David Quinn — ASN Events

David Quinn — ASN Events

, ,

Presentations this author is a contributor to:

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: The P3BEP Trial (ANZUP 1302) (#266)